Harrington Group Limited

ASX:HGR ISIN:AU000000HGR9

Feb 10, 2012

OVERVIEW | NEWS | MULTIMEDIA | RESEARCH

Harrington Group Limited Company Summary

Harrington Group Ltd is a public company listed on the Australian Stock Exchange (ASX) under the symbol "HGR". As a publicly listed entity HGR has undergone a number of evolutions moving from an organisation with a diverse portfolio of investments to the present organisation which is clearly focused on the invitro diagnostics market.

Through the acquisition of Sun Biomedical Laboratories Inc (SBL), HGR has acquired a portfolio of unique invitro diagnostic intellectual property with a specific focus and expertise in the use of saliva as the diagnostic medium. The immediate opportunity to be realised through SBL is the global commercialisation of their benchmark oral-fluid illicit drug screening device OraLine which has established an industry benchmark with the most sensitive detection levels particularly for marijuana which is the most commonly consumed illicit substance both in Australia, the United States and throughout Europe.

COMPANY DATA

	Fax	08) 9324 8581

	Principal Sector	Int'l Trade

	Principal Industry	Capital Goods

	Listed	1993/02/04

	Homepage	www.hgrltd.com

Key Developments: Harrington Group Limited

	Harrington Group Files 510(k) For Saliva Drug Screening Device Oraline OCT 24, 2007 12:58 - Article Views: 1,850 Harrington Group (ASX: HGR) advises that having completed the necessary studies the Company's subsidiary Sun Biomedical Laboratories (SBL) has filed for US Food and Drug Administration (FDA) 510(k) clearance for the Company's saliva illicit drug screening device OraLine.